drugset / Trial / NCT06217627

Skin Rejuvenation Using Stem Cell Secretome

NCT06217627

Phase 1 Completed 49 enrolled COR clinic of Regenerative Medicine
RandomizedSingle-groupOpen-labelTreatment

Summary

This clinical trial aims to investigate the effect of umbilical cord explants (UC)-explants and UC-mesenchymal stem cells (MSCs) secretome on skin rejuvenation, to provide future reference or standard in the application of cell free-based therapy in skin aging.

Timeline

Start
2021-03-05
Primary completion
2023-01-25
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Secretome Other / unclassified

Indications

No indication recorded.